Xponance’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $637K | Sell |
4,971
-50
| -1% | -$6.41K | 0.01% | 861 |
|
|
2025
Q1 | $444K | Buy |
5,021
+240
| +5% | +$21.2K | ﹤0.01% | 974 |
|
|
2024
Q4 | $417K | Buy |
4,781
+525
| +12% | +$45.8K | ﹤0.01% | 1009 |
|
|
2024
Q3 | $394K | Buy |
4,256
+82
| +2% | +$7.59K | ﹤0.01% | 1011 |
|
|
2024
Q2 | $450K | Buy |
4,174
+315
| +8% | +$34K | ﹤0.01% | 938 |
|
|
2024
Q1 | $366K | Sell |
3,859
-239
| -6% | -$22.7K | ﹤0.01% | 1029 |
|
|
2023
Q4 | $378K | Buy |
+4,098
| New | +$378K | ﹤0.01% | 1013 |
|
|
2023
Q3 | – | Sell |
-3,556
| Closed | -$225K | – | 1245 |
|
|
2023
Q2 | $225K | Buy |
+3,556
| New | +$225K | ﹤0.01% | 1119 |
|
|
2022
Q4 | – | Sell |
-3,364
| Closed | -$222K | – | 1236 |
|
|
2022
Q3 | $222K | Buy |
+3,364
| New | +$222K | ﹤0.01% | 1067 |
|
|
2022
Q1 | – | Sell |
-2,825
| Closed | -$303K | – | 1172 |
|
|
2021
Q4 | $303K | Buy |
2,825
+22
| +0.8% | +$2.36K | ﹤0.01% | 1037 |
|
|
2021
Q3 | $288K | Sell |
2,803
-455
| -14% | -$46.8K | 0.01% | 1049 |
|
|
2021
Q2 | $287K | Buy |
+3,258
| New | +$287K | 0.01% | 1080 |
|